Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-14-0337
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Therapeutic Targeting of Non-Oncogene Dependencies in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

MYCN Controls an Alternative RNA Splicing Program in High-Risk Metastatic Neuroblastoma

Cancer Letters
Cancer ResearchOncology
2016English

Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Abnormalities in Alternative Splicing in Diabetes: Therapeutic Targets

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2017English

DNMTs as Potential Therapeutic Targets in High-Risk Pediatric Embryonal Brain Tumors

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

BET Bromodomain Proteins Are Therapeutic Targets in CRPC

Cancer Discovery
Oncology
2014English

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Scientific Reports
Multidisciplinary
2018English

EphrinB3 and EphrinB4 Receptors Are Potential Therapeutic Targets in Glioblastoma

Canadian Journal of Neurological Sciences
MedicineNeurology
2015English

Telomere Maintenance Is Pivotal for High-Risk Neuroblastoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy